Vrba Jiří, Papoušková Barbora, Kosina Pavel, Lněničková Kateřina, Valentová Kateřina, Ulrichová Jitka
Department of Medical Chemistry and Biochemistry, Faculty of Medicine and Dentistry, Palacký University, Hněvotínská 3, 77515 Olomouc, Czech Republic.
Regional Centre of Advanced Technologies and Materials, Department of Analytical Chemistry, Faculty of Science, Palacký University, 17. Listopadu 12, 77146 Olomouc, Czech Republic.
Metabolites. 2020 Aug 12;10(8):329. doi: 10.3390/metabo10080329.
Natural phenolic compounds are known to be metabolized by phase II metabolic reactions. In this study, we examined the in vitro sulfation of the main constituents of silymarin, an herbal remedy produced from the fruits of the milk thistle. The study focused on major flavonolignan constituents, including silybin A, silybin B, isosilybin A, isosilybin B, silychristin, and silydianin, as well as the flavonoid taxifolin. Using ultra-high-performance liquid chromatography coupled with tandem mass spectrometry (UHPLC-MS), individual flavonolignans and taxifolin were found to be sulfated by human liver and human intestinal cytosols. Moreover, experiments with recombinant enzymes revealed that human sulfotransferases (SULTs) 1A11, 1A12, 1A2, 1A3, 1B1, 1C4, and 1E1 catalyzed the sulfation of all of the tested compounds, with the exception of silydianin, which was not sulfated by SULT1B1 and SULT1C4. The sulfation products detected were monosulfates, of which some of the major ones were identified as silybin A 20--sulfate, silybin B 20--sulfate, and isosilybin A 20--sulfate. Further, we also observed the sulfation of the tested compounds when they were tested in the silymarin mixture. Sulfates of flavonolignans and of taxifolin were produced by incubating silymarin with all of the above SULT enzymes, with human liver and intestinal cytosols, and also with human hepatocytes, even though the spectrum and amount of the sulfates varied among the metabolic models. Considering our results and the expression patterns of human sulfotransferases in metabolic tissues, we conclude that flavonolignans and taxifolin can potentially undergo both intestinal and hepatic sulfation, and that SULTs 1A1, 1A3, 1B1, and 1E1 could be involved in the biotransformation of the constituents of silymarin.
已知天然酚类化合物可通过Ⅱ相代谢反应进行代谢。在本研究中,我们检测了水飞蓟素主要成分的体外硫酸化作用,水飞蓟素是一种由水飞蓟果实制成的草药。该研究聚焦于主要的黄酮木脂素成分,包括水飞蓟宾A、水飞蓟宾B、异水飞蓟宾A、异水飞蓟宾B、水飞蓟亭和水飞蓟宁,以及黄酮类化合物紫杉叶素。使用超高效液相色谱-串联质谱法(UHPLC-MS),发现人肝脏和人肠道胞质溶胶可使单个黄酮木脂素和紫杉叶素发生硫酸化。此外,重组酶实验表明,人磺基转移酶(SULTs)1A11、1A12、1A2、1A3、1B1、1C4和1E1催化了所有测试化合物的硫酸化反应,但水飞蓟宁除外,它不会被SULT1B1和SULT1C4硫酸化。检测到的硫酸化产物为单硫酸盐,其中一些主要产物被鉴定为水飞蓟宾A 20-硫酸盐、水飞蓟宾B 20-硫酸盐和异水飞蓟宾A 20-硫酸盐。此外,当在水飞蓟素混合物中对测试化合物进行检测时,我们也观察到了它们的硫酸化作用。通过将水飞蓟素与上述所有SULT酶、人肝脏和肠道胞质溶胶以及人肝细胞一起孵育,可产生黄酮木脂素和紫杉叶素的硫酸盐,尽管在不同代谢模型中硫酸盐的种类和数量有所不同。综合我们的研究结果以及人磺基转移酶在代谢组织中的表达模式,我们得出结论,黄酮木脂素和紫杉叶素可能在肠道和肝脏中都发生硫酸化,并且SULTs 1A1、1A3、1B